Who Benefits from Multiparametric Magnetic Resonance Imaging After Suspicion of Prostate Cancer?

Prostate cancer (PC) suspicion is based on prostate-specific antigen (PSA) and digital rectal examination (DRE). Multiparametric magnetic resonance imaging (mpMRI) increases prostate biopsy (PBx) specificity and sensitivity for detection of aggressive PC. To identify who benefits from mpMRI accordin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European urology oncology 2019-11, Vol.2 (6), p.664-669
Hauptverfasser:	Morote, Juan, Celma, Anna, Roche, Sarai, de Torres, Inés M., Mast, Richard, Semedey, Maria E., Regis, Lucas, Planas, Jacques
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aggressive prostate cancer Biopsy Digital Rectal Examination Early Diagnosis Humans Male Middle Aged Multiparametric Magnetic Resonance Imaging Prostate cancer Prostate-Specific Antigen - blood Prostatic Neoplasms - diagnosis Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Prostate cancer (PC) suspicion is based on prostate-specific antigen (PSA) and digital rectal examination (DRE). Multiparametric magnetic resonance imaging (mpMRI) increases prostate biopsy (PBx) specificity and sensitivity for detection of aggressive PC. To identify who benefits from mpMRI according to biopsy scenario (initial biopsy [IBx] vs repeated biopsy [RBx]) and the risk of aggressive PC according to PSA-DRE groups (G1, PSA
ISSN:	2588-9311 2588-9311
DOI:	10.1016/j.euo.2018.11.009